INDOUS vs MODINATUR: Stock Comparison

Indo Us Biotech Limited vs Modi Naturals Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Modi Naturals Ltd is the larger company by market capitalisation. Indo Us Biotech Limited shows a lower P/E, a higher dividend yield and lower leverage, while Modi Naturals Ltd shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indo Us Biotech Limited and Modi Naturals Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDOUS is more favourable on 7 of 13 scored metrics and MODINATUR on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
MODINATUR is the larger company
₹563 Cr vs ₹170 Cr
P/E Ratio
INDOUS has a lower P/E
0x vs 11.19x
P/B Ratio
INDOUS has a lower P/B
0x vs 3.27x
EPS
MODINATUR has higher earnings per share
₹27.5 vs ₹6.54
Dividend Yield
INDOUS has a higher dividend yield
0.29% vs 0%
Revenue Growth (TTM YoY)
MODINATUR has faster revenue growth
0% vs -22%
EPS Growth (TTM YoY)
MODINATUR has faster EPS growth
0% vs -47.3%
Qtr Sales Growth
INDOUS has stronger quarterly sales growth
5.64% vs 0.29%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDOUSMODINATUR
SectorFast Moving Consumer Goods
IndustryOther Agricultural Products

Price

MetricINDOUSMODINATUR
Live Price₹84.98₹460.4
Day Change-2.24%-0.46%
Volume17,31129,351
52-Week High₹182.1₹524.8
52-Week Low₹84.91₹252.3
Distance from 52W High-53.33%-12.27%

Valuation

MetricINDOUSMODINATUR
Market Cap₹170 Cr₹563 Cr
P/E Ratio0x11.19x
P/B Ratio0x3.27x
EPS₹6.54₹27.5
Book Value₹45.99₹107
Dividend Yield0.29%0%

Growth

MetricINDOUSMODINATUR
Revenue Growth (TTM YoY)-22%0%
EPS Growth (TTM YoY)-47.3%0%
Qtr Sales Growth5.64%0.29%
Qtr Profit Growth-24%32.8%

Profitability & Leverage

MetricINDOUSMODINATUR
ROE16.9%29.21%
ROCE15.4%18.7%
Net Margin11.88%6.99%
Operating Margin13.8%9.92%
Debt to Equity0.33x0.94x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDOUSMODINATUR
Promoter Holding68.29%69.09%
FII Holding0.01% 0.17 pp0%
DII Holding0%
Public Holding31.7% 0.17 pp30.91%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indo Us Biotech Limited and Modi Naturals Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.